Literature DB >> 32697166

Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.

Richard K Do1, Mishal Mendiratta-Lala1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32697166      PMCID： PMC7457932          DOI： 10.1148/radiol.2020202637

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  8 in total

1.  LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.

Authors:  Se Woo Kim; Ijin Joo; Hyo-Cheol Kim; Su Joa Ahn; Hyo-Jin Kang; Sun Kyung Jeon; Jeong Min Lee
Journal:  Eur Radiol       Date:  2020-01-31       Impact factor: 5.315

2.  The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.

Authors:  Mohammad Chaudhry; Katrina A McGinty; Benjamin Mervak; Reginald Lerebours; Cai Li; Erin Shropshire; James Ronald; Leah Commander; Johann Hertel; Sheng Luo; Mustafa R Bashir; Lauren M B Burke
Journal:  Radiology       Date:  2019-12-17       Impact factor: 11.105

Review 3.  Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.

Authors:  Ania Kielar; Kathryn J Fowler; Sara Lewis; Vahid Yaghmai; Frank H Miller; Hooman Yarmohammadi; Charles Kim; Victoria Chernyak; Takeshi Yokoo; Jeffrey Meyer; Isabel Newton; Richard K Do
Journal:  Abdom Radiol (NY)       Date:  2018-01

4.  LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.

Authors:  Richard K Do; Mishal Mendiratta-Lala
Journal:  Radiology       Date:  2019-12-17       Impact factor: 11.105

Review 5.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

6.  Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.

Authors:  Nieun Seo; Myoung Soo Kim; Mi-Suk Park; Jin-Young Choi; Richard K G Do; Kyunghwa Han; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2019-08-15       Impact factor: 5.315

7.  Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.

Authors:  Sungeun Park; Ijin Joo; Dong Ho Lee; Jae Seok Bae; Jeongin Yoo; Se Woo Kim; Jeong Min Lee
Journal:  Radiology       Date:  2020-07-21       Impact factor: 11.105

8.  LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.

Authors:  Erin L Shropshire; Mohammad Chaudhry; Chad M Miller; Brian C Allen; Erol Bozdogan; Diana M Cardona; Lindsay Y King; Gemini L Janas; Richard K Do; Charles Y Kim; James Ronald; Mustafa R Bashir
Journal:  Radiology       Date:  2019-04-30       Impact factor: 29.146
  8 in total
  2 in total

Review 1.  Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Authors:  Anum Aslam; Amita Kamath; Bradley Spieler; Mark Maschiocchi; Carl F Sabottke; Victoria Chernyak; Sara C Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-15

2.  LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data.

Authors:  Tae-Hyung Kim; Sungmin Woo; Ijin Joo; Mustafa R Bashir; Mi-Suk Park; Lauren M B Burke; Mishal Mendiratta-Lala; Richard K G Do
Journal:  Abdom Radiol (NY)       Date:  2021-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.